AstraZeneca admits rare blood clot risk from covid jabs as it faces class action lawsuit in UK

Bilgin

Global Mod
Global Mod
AstraZeneca admits rare blood clot risk from covid jabs as it faces class action lawsuit in UK Facing a class action lawsuit in the UK, the drug company acknowledged a rare blood clotting risk from covid jabs.
 
Üst